PharmaCyte Biotech Inc (PMCB)

[Traderintx]

The free fall will continue. Until NVLX proves they have viable technology the PPS will be on a collision course with 0.001. There is a lot of talk about what they are going to do but still no real accomplishments have been made. Speculative companies like NVLX have to prove naysayers wrong with actual results and not "we're going to do this" Until that happens this slide will keep going.

I would be comfortable adding in .01-.03 range based on what their total assets are worth. Paying any more than that is overpaying.

I also think the definition of "Due Diligence" is misused on this site. Due diligence is not just taking all of the positive information and basing a decision solely on that information. One must account for risk factors and consider realistic probabilities for success.